March 2014 Issue Table Of Contents

From The Editor

• What Gives With The New Look?

Capitol Perspectives

• Distortions Bedevil Obamacare Implementation

Companies To Watch

• Companies To Watch: Otonomy Develops Proprietary Formulation For Ménière's Disease

Outsourcing Insights

• Outsourcing Solid Dose Manufacturing Trends In 2014

Bio Innovation notes

• Best Practices In Biomanufacturing Supplier Relations: Reducing Raw Materials Risks

Features

• Paul Stoffels Expands The Janssen Legacy
• Medicago’s Innovative Vaccine Production Using Tobacco Plants
• Dennis Purcell Building On Last Year’s Biotech Boom In 2014
• Maintaining Momentum: 2014 Pharma & Funding Forecasts At JPMHCC

Inside The Industry

• How Rare Disease Know-how Can Shape Big Pharma Clinical Trials
• Transform Clinical Trials By Embracing M2M Technology
• Nonantibiotics Spur Biotech-Pharma Collaborations
• Patient-Centric Design: The Next Frontier In Drug Delivery
• Serilalization – Pharma Faces 2015 Deadline
• Evolva Turns Around Its Business Model: Swiss Biotech Opts Out Of Drug Development

Industry Leader

• How Patent Translation Can Affect Your Bottom Line

Leadership Lessons

• 4 Power-Thinking Strategies Of Centered Leaders

Ask The Board

• What Is The Best Leadership Advice You Ever Received?